Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community

Bibliographic Details
Title: Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community
Authors: Sara Alamyar, Elizabeth Azzi, Pamela Srour-Alphonse, Rachel House, Biljana Cvetkovski, Vicky Kritikos, Sinthia Bosnic-Anticevich
Source: Pharmacy, Vol 11, Iss 4, p 115 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Pharmacy and materia medica
Subject Terms: allergic rhinitis, asthma, attitudes, behaviors, medication, perception, Pharmacy and materia medica, RS1-441
More Details: Asthma and rhinitis are common comorbidities that amplify the burden of each disease. They are both characterized by poor symptom control, low adherence to clinical management guidelines, and high levels of patient self-management. Therefore, this study aims to investigate the prevalence of self-reported rhinitis symptoms in people with asthma purchasing Short-Acting Beta Agonist (SABA) reliever medication from a community pharmacy and compare the medication-related behavioral characteristics among those who self-report rhinitis symptoms and those who do not. Data were analyzed from 333 people with asthma who visited one of eighteen community pharmacies in New South Wales from 2017–2018 to purchase SABA and completed a self-administered questionnaire. Participants who reported rhinitis symptoms (71%), compared to those who did not, were significantly more likely to have coexisting gastroesophageal reflux disease (GERD), overuse SABA, and experience side effects. They may have been prescribed daily preventer medication but forget to take it, and worry about its side effects. They were also more likely to experience moderate-to-severe rhinitis (74.0%), inaccurately perceive their asthma as well-controlled (50.0% self-determined vs. 14.8% clinical-guideline defined), and unlikely to use rhinitis medications (26.2%) or daily preventer medication (26.7%). These findings enhance our understanding of this cohort and allow us to identify interventions to improve patient outcomes.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2226-4787
Relation: https://www.mdpi.com/2226-4787/11/4/115; https://doaj.org/toc/2226-4787
DOI: 10.3390/pharmacy11040115
Access URL: https://doaj.org/article/4033934233a84c8d8ca2da990fcb625e
Accession Number: edsdoj.4033934233a84c8d8ca2da990fcb625e
Database: Directory of Open Access Journals
More Details
ISSN:22264787
DOI:10.3390/pharmacy11040115
Published in:Pharmacy
Language:English